about
Human African Trypanosomiasis in the Democratic Republic of the Congo: A Looming Emergency?Mortality among PCR negative admitted Ebola suspects during the 2014/15 outbreak in Conakry, Guinea: A retrospective cohort study.Seroprevalence of transfusion-transmissible infections and evaluation of the pre-donation screening performance at the Provincial Hospital of Tete, Mozambique.One size fits all? Standardised provision of care for survivors of sexual violence in conflict and post-conflict areas in the Democratic Republic of Congo.Challenges in developing national HIV guidelines: experience from the eastern MediterraneanHepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in CambodiaProzone in malaria rapid diagnostics tests: how many cases are missed?Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014-2015 outbreak.Organizing the Donation of Convalescent Plasma for a Therapeutic Clinical Trial on Ebola Virus Disease: The Experience in GuineaElectrolyte and Metabolic Disturbances in Ebola Patients during a Clinical Trial, Guinea, 2015.Treatment practices in patients with suspected malaria in Provincial Hospital of Tete, Mozambique.Burden and outcome of HIV infection and other morbidities in health care workers attending an Occupational Health Program at the Provincial Hospital of Tete, Mozambique.A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screening.Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea.Time for "test and treat" in prevention of mother-to-child transmission programs in low- and middle-income countries.Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: a pharmaceutical standpointRational use of Xpert testing in patients with presumptive TB: clinicians should be encouraged to use the test-treat threshold.High mortality in non-Ebola virus disease cases: need to provide timely and effective care.Localised transmission hotspots of a typhoid fever outbreak in the Democratic Republic of Congo.Symptom-Based Ebola Risk Score for Ebola Virus Disease, Conakry, Guinea.Correction: Performance of the PointCare NOW System for CD4 Counting in HIV Patients Based on Five Independent Evaluations.Typhoid fever outbreak in the Democratic Republic of Congo: Case control and ecological studyTreatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trialClinical Evaluation of QuickNaviTM-Ebola in the 2018 Outbreak of Ebola Virus Disease in the Democratic Republic of the CongoChallenges to Differente Hepatitis C Genotype 1 and 6: Results from a Field Study in Cambodia
P50
Q29056943-E4B82A84-8F9C-4BD7-99CF-E2273AC21381Q33860073-E08F5FDA-3659-4FB0-A49D-3E300AE9BFA3Q33909168-03AF5E68-2686-4194-87F7-8485A6C0EEE7Q34374363-E7F3001A-8CEE-4DDB-8B6B-D0FABCFA895BQ34997637-02180CC1-6545-45FB-80BF-7B8196F7A825Q35095416-56303D16-1544-4685-90E3-8E88412A5A19Q35121977-A5462B0B-1D42-44DA-999C-2DEB82F39EF2Q36536012-6AA4CEAC-A5B8-4679-9935-64AB8D916F8BQ37238452-833D521C-5EE1-4783-8365-89E9F2A3E6B8Q37535900-AB42A5BF-EB41-4EAC-9C2D-DD11EBE12111Q38916122-489377B2-F802-4820-9056-E28018AB81FFQ38933748-F42376AA-2E5C-4CB3-9981-55C5B067C020Q38967636-672F953E-53A8-4895-9669-AA2D3F59B364Q39550507-E478BEC6-7C5D-4CC9-B2FB-FE76DF7931D4Q39633301-AB6A6450-D823-4161-8CEB-D28CD872B90AQ42329781-5ACF6A84-8F42-4BD6-BB41-EDE11FF4E2C7Q42375069-0D28C26F-A154-4582-93EB-431FB8B24DBBQ44105766-56ACAF6D-4B93-41E2-BD95-8E84F8DA1302Q51783739-234F6677-2F2E-4C72-9BCE-987B6D0CE8BDQ55239787-B104767D-CE80-4AB3-92B9-ED7AD944A19DQ55270525-2AFA355B-1619-4F4B-AC90-AEE9C7124A12Q57040721-6308B418-A5BF-4789-9400-49C3EC02384FQ91124009-622B0CEC-58D9-40EA-8354-5D30706F31CBQ91517805-646B8E4B-205C-4D16-B6DF-648732A6C088Q96034158-756C6107-D59B-449E-BAC5-018B28490F90
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anja De Weggheleire
@ast
Anja De Weggheleire
@en
Anja De Weggheleire
@es
Anja De Weggheleire
@nl
Anja De Weggheleire
@sl
type
label
Anja De Weggheleire
@ast
Anja De Weggheleire
@en
Anja De Weggheleire
@es
Anja De Weggheleire
@nl
Anja De Weggheleire
@sl
prefLabel
Anja De Weggheleire
@ast
Anja De Weggheleire
@en
Anja De Weggheleire
@es
Anja De Weggheleire
@nl
Anja De Weggheleire
@sl
P106
P21
P31
P496
0000-0001-9377-4766